1 Office fédéral de la santé publique OFSP. VIH, syphilis, gonorrhée et chlamydiose en Suisse en 2017 : survol épidémiologique. Bulletin OFSP 47 du 19 novembre 2018.
2 LaDuca JR, Love JL, Abbott LZ, Dube S, Freidman-Kien AE, Poiesz BJ. Detection of human herpesvirus 8 DNA sequences in tissues and bodily fluids. J Infect Dis. 1998;178(6):1610–5.
3 Antman K, Chang Y. Kaposi’s sarcoma. N Engl J Med. 2000;342(14):1027–38.
4 Andreoni M, Sarmati L, Nicastri E, El Sawaf G, El Zalabani M, Uccella I et al. Primary human herpesvirus 8 infection in immunocompetent children. JAMA. 2002;287(10):1295–300.
5 Dean SM, Kaffenberger BH, Lustberg ME. Kaposi sarcoma: an unconventional cause of lower extremity lymphœdema. Vasc Med. 2017; 22(6):544.
6 Hengge UR, Stocks K, Goos M. Acquired immune deficiency syndrome-related hyperkeratotic Kaposi’s sarcoma with severe lymphœdema: report of five cases. Br J Dermatol. 2000;142:501–5.
7 Caponetti G, Dezube BJ, Restrepo CS, Pantanowitz L. Kaposi sarcoma of the musculoskeletal system: a review of 66 patients. Cancer. 2007;109(6):1040–52.
8 Dirweesh A, Khan MY, Hamiz SF, Karabulut N. Pulmonary Kaposi sarcoma with osseous metastases in an Human Immunodeficiency Virus (HIV) patient: A remarkable response to highly active antiretroviral therapy. Am J Case Rep. 2017;18:181–5.